Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2×2×2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimod

2×2×2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimod

US Patent 8236816 · Granted Aug 7, 2012

Estimated economic value: $10,255,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Acute delivery of a drug or fluid to an ocular surface2025
Lower dosage strength imiquimod formulations and short dosing regimens for treat2023
2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical com2022
2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical com2022
2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical com2022
2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical com2022
2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical com2022
2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical com2022
2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical com2022
2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical com2022
2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical com2022
Methods of treating dermatological disorders and inducing interferon biosynthesi2021